ENOV Stock Analysis: Buy, Sell, or Hold?
ENOV - Enovis Corporation
$24.29
-1.83 (-7.01%)
▼
5d:
-8.41%
30d:
-3.61%
90d:
+11.58%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When ENOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ENOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.42
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$23.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENOV is currently trading at $24.29, which is considered extended relative to its 30-day fair value range of $23.16 to $25.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.0) compared to its historical average (6.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.7% over the next few years. This pessimistic expectation contrasts with the company's recent 153.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ENOV is showing sideways momentum. Immediate support is located at $22.99, while resistance sits at $27.89. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ENOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $43.00 (+77.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENOV is showing sideways momentum. Immediate support is located at $22.99, while resistance sits at $27.89. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: ENOV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $43.00 (+77.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.16 -
$25.67
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 77.0% below Wall St target ($43.00)
- CAUTION: 5-day price weakness (-8.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$23.16 -
$25.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$22.99
Resistance Level
$27.89
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.02
Wall Street Target
$43.00
(+77.0%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
153.1%
Profit Margin
-49.9%
Valuation Discount vs History
-3.7% cheaper
PE vs Historical
6.0 vs 6.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.7%
(market-implied from PE analysis)
1-Year Target
$23.39
(-4%)
2-Year Target
$22.53
(-7%)
3-Year Target
$21.69
(-11%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$24.15
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 10.6%)
$120.63
(+397%)
Base:
(SPY PE: 6.0, Growth: 10.6%)
$32.89
(+35%)
Bear:
(PE: 5.1, Growth: 10.6%)
$27.96
(+15%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.0 to 6.7
Stabilization Target:
$27.04
(+11.3%)
PE Expansion Potential:
+11.3%
Share & Embed Analysis
Last updated: May 15, 2026 11:36 PM ET
Data refreshes hourly during market hours. Next update: 12:36 AM
Data refreshes hourly during market hours. Next update: 12:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENOV showing a specific setup today?
Insider Activity (6 Months)
7
Buys
2
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Oliver Engert
BUY
1000 shares
2026-03-13
Oliver Engert
BUY
1000 shares
2026-03-09
Oliver Engert
BUY
750 shares
2026-03-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
